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The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc to human beings around the
world. Although China quickly brought the Coronavirus disease (COVID-19) pandemic under control, there have been several
sporadic outbreaks in different regions of China since then. This article describes the chronological nosocomial COVID-19 infection
events that related to several sporadic outbreaks of SARS-CoV-2 in different regions of China. We reported epidemiological
characteristics and management measures of sporadic nosocomial COVID-19 infections from June 2020 to June 2021 in China,
specially focused on domestic COVID-19 breakthrough infection in China — a vaccinated healthcare professional working in the
isolation ward of a designated COVID-19 hospital.
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The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked 20 
havoc to millions of people around the world. Although China quickly brought the Coronavirus 21 
disease (COVID-19) under control, there have been several sporadic outbreaks in different regions 22 
of China since June 2020. This article describes the chronological nosocomial COVID-19 23 
infection events related to several sporadic outbreaks of SARS-CoV-2 in different regions of 24 
China. We report epidemiological characteristics and management measures of sporadic 25 
nosocomial COVID-19 infections from June 2020 to June 2021, and specially focused on the 26 
domestic COVID-19 breakthrough infection in China including domestic COVID-19 27 
breakthrough infection - a vaccinated healthcare professional working in the isolation ward of a 28 
designated COVID-19 hospital. 29 
Keywords: COVID-19 disease; asymptomatic carrier; nosocomial infection; Scientific protective 30 
strategy; vaccine breakthrough infection 31 




The outbreak of the COVID-19 virus was first reported in Wuhan, China, in December 2019. The 34 
COVID-19 pandemic led China to quarantine the population in order to protect them 1. Chinese 35 
authorities decided to adopt extraordinary measures to contain and limit the spread of the SARS-36 
CoV-2 virus. From 1 January to 8 April 2020, >8,000 patients with COVID-19 were hospitalized 37 
and the Chinese government imposed the Wuhan lockdown on January 23, which ended on April 8, 38 
2020. 39 
 40 
With the COVID-19 epidemic quickly under control in the early stages of 2020, importing the 41 
SARS-CoV-2 virus could pose great challenges to the control and prevention of nosocomial 42 
COVID-19 infection in healthcare settings. Our previous report showed the impact of the novel 43 
coronavirus SARS-CoV-2 among healthcare workers in hospitals during the early phase of the 44 
COVID-19 epidemic2, and suggested that local authorities need to be extremely cautious and 45 
implement stringent protective measures to safeguard healthcare workers in order to counteract the 46 
threats brought by the pandemic3-5. Though medical staff belong to the susceptible population to a 47 
certain extent, hospitals have practiced cohorting in accordance with recommendations from 48 
COVID-19 infection prevention and control professional societies, which has reduced the risk of 49 
hospital-acquired COVID-19. Because healthcare workers are at the interface between hospitals and 50 
the community, where there is significant COVID-19 transmission, they may be infected by 51 
asymptomatic carriers with COVID-19 or COVID-19 patients. Furthermore, in the designated 52 
hospital admitting COVID-19 patients or asymptomatic carriers, medical staff are highly exposed 53 
to nosocomial COVID-19 acquisition and SARS-CoV-2 transmission. Therefore, healthcare staff 54 
may play a key role in initiating or amplifying sporadic COVID-19 outbreaks in healthcare settings 55 
including hospitals and other care facilities. 56 
 57 
The importing of the SARS-CoV-2 virus from overseas, induced sporadic outbreaks with COVID-58 
19 from June 2020 to June 2021 in China6, 7. This article describes the chronological events that led 59 
to several sporadic nosocomial COVID-19 infections in different regions of China from June 2020 60 
to June 2021, including domestic COVID-19 breakthrough infection — a vaccinated healthcare 61 
professional working in the isolation ward of a designated COVID-19 hospital8. Lastly, we provide 62 
an overview of local COVID-19 outbreak induced by the B.1.617.2 (Delta) variant of the COVID-63 
19 virus in China. 64 
 65 
Methods 66 
From the beginning of June 1, 2020, every day, we prospectively focused on the COVID-19 67 
epidemic data from the Chinese Center for Disease Control and Prevention. Once we had the new 68 
report of nosocomial COVID-19 infection in China, we tracked this epidemic and collected its 69 
epidemiological characteristics from announcements by the local Health Commission and presented 70 
a narrative research for geographical and epidemiological characteristics of nosocomial COVID-19 71 
infection from June 2020 to June 2021. 72 
 73 
We searched epidemiologic data published on the website of WHO, the China Center for Disease 74 
Control and Prevention, National Health Commission, the Health Commission of Qingdao, 75 
Shenyang, Shijiazhuang, and Dalian city, Jilin, Shaanxi, and Guangdong Province from June 2020 76 
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to January 2021. Using the keywords “nosocomial infection”, “COVID-19 variant”, “SARS-CoV-77 
2”, “B1.617.2 (Delta) lineage”, and Boolean operator ‘AND’, we periodically searched the 78 
published medical literature using the PubMed service maintained by the U.S. National Library of 79 
Medicine of NIH. Confirmed COVID-19 cases are defined as persons who tested positive for SARS-80 
CoV-2 and had clinical symptoms. Asymptomatic carriers refer to persons without clinical 81 
symptoms who tested positive for SARS-CoV-2.  82 
 83 
Results  84 
Regional distribution of nosocomial COVID-19 infections from June 2020 to June 2021  85 
From June 2020 to June 2021, regional distribution of the sporadic nosocomial COVID-19 86 
infections is shown in Figure 1, 2 and Table 1. Most of these cities are located in coastal or  airline 87 
hub areas, for example, Dalian, Qingdao, Shanghai are coastal cities, and Xi’an, Shenyang, 88 
Shijiazhuang, and Guangzhou are airline hub cities. 89 
 90 
Occupational distribution of nosocomial COVID-19 infections from June 2020 to June 2021  91 
From June 2020 to June 2021, six cities in China had reported over 45 cases with nosocomial 92 
COVID-19 infections, including 39 confirmed cases and 6 asymptomatic cases (Table 2). Among 93 
them, nursing staff (3), doctors (6), patients (12), accompanying staff (22), and laboratorian (2) were 94 
diagnosed. The route of these nosocomial infections mainly included workplace accidental exposure 95 
to COVID-19, cross infection among healthcare workers, patients, and accompanying staff. 96 
 97 
SARS-CoV-2 gene sequencing results of nosocomial COVID-19 infections from June 2020 to 98 
June 2021 99 
SARS-CoV-2 gene sequencing is crucial work for nosocomial COVID-19 infections in new 100 
sporadic outbreak regions. The virus strain of nosocomial COVID-19 infection found in Qingdao 101 
city is the virus strain lineage B.1.1 imported from overseas (Table 2). Gene sequencing results 102 
showed that the coronavirus found in Dalian, Shenyang, and Shijiazhuang cities is similar to the 103 
strain imported from Europe; The virus strain found in Xi’an city is a COVID-19 variant B.1.1.7 104 
lineage; SARS-CoV-2 strain found in Guangzhou city is the imported virus strain B1.617.2 (Delta) 105 
lineage (Table 2). 106 
A report from Fang et al9 showed that the strains associated with specific outbreak in Dalian City 107 
were as follows: LNDL-BHQ-0722-Y_S12_L001_R1_001, LNDL-SFL-0722-108 
Y_S9_L001_R1_001, LNDL-WY-0722-Y_S11_L001_R1_001, and LNDL-XY-0722-109 
Y_S10_L001_R1_001; The parent strain from Wuhan was 110 
NC_045512.2_Severe_acute_respiratory_syndrome_coronavirus_2_isolate_Wuhan-Hu-111 
1_complete_genome. After accessing the public database GISAID and GenBank, 3 Russian strains 112 
detected in July were found to share the 10 variation sites with the 2 Hebei strains (GISAID IDs: 113 
EPI_ISL_596266, EPI_ISL_569792, and EPI_ISL_569793)10. Evidence indicates that these the 114 
Shijiazhuang strains may have originated from these Russian strains10. 115 
 116 
Discussion 117 
This paper provides us with an inspiring vision regarding the current COVID-19 pandemic. The 118 
main findings of sporadic nosocomial COVID-19 infections from June 2020 to June 2021 are listed 119 
below: (1) the importance of rolling out an overall nucleic acid test campaign to all staff in healthcare 120 
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settings, is a crucial part of the COVID-19 surveillance; (2) The case of coronavirus transported 121 
onto the workplace warns us that the current hospital disinfection concept urgently requires updating, 122 
especially in designated hospitals, and there is an urgent demand of the management of staff 123 
accompanying patients in non-designated hospitals ; (3) The phenomenon about COVID-19 vaccine 124 
breakthrough infection deserves our great attention. 125 
For healthcare workers, patients/accompanying staff, and cleaner, their COVID-19 infection may 126 
be from hospital (hospital-acquired infection, also nosocomial infection) or community 127 
(community-acquired infection). Distinguishing nosocomial infection and community-acquired 128 
infection is an important base to control the epidemic in nosocomial COVID-19 infections. Because 129 
healthcare workers are at the interface between hospitals and the community, where there is 130 
significant COVID-19 transmission, they may be infected by asymptomatic carriers from the 131 
community with COVID-19 or COVID-19 patients. These healthcare workers (infected in the 132 
community) do not belong to nosocomial infection (also called hospital-acquired infection). For 133 
example, in Figure 1, the infected cases (including healthcare workers, cleaner, etc.) in Beijing, 134 
Dalian (27 Dec. 2020) and Shanghai were community-acquired infection, not nosocomial infection. 135 
For nosocomial infection of healthcare workers, patients/accompanying staff, and cleaner, as the 136 
effective control measures taken by the local government must include: (1) these hospitals imposed 137 
lockdown, especially in the designated COVID-19 hospital; (2) rolling out an overall nucleic acid 138 
test campaign to all staff is key in healthcare settings. 139 
 140 
Among 9 sporadic nosocomial COVID-19 infections, our results showed that 8 series cases were 141 
found by rolling out overall a nucleic acid test campaign to all hospital staff, suggesting the 142 
importance of regular screening for all staff in healthcare settings. As part of efforts to control the 143 
COVID-19 infections, one of the effective prevention measures taken by local authorities is that all 144 
hospital personnel labeled a key population are closely monitored7. Whether the epidemic in 145 
nosocomial COVID-19 infections can be brought under control depends on how many new 146 
infections emerge of their close contacts and secondary close contacts in the next two weeks. If 147 
these hospitals imposed lockdown as the effective control measures taken by the local government, 148 
then ideally, new confirmed cases with COVID-19 infections will see a downward trend within two 149 
weeks. Cases such as hospital-acquired infection in the designated hospital of Qingdao city are a 150 
warning that workplace storage and transport could be a hotbed for the coronavirus, or other 151 
pathogens. There is an urgent demand for workplace disinfection to protect the health safety of 152 
medical staff, patients, and accompanying staff in the current pandemic or into another worse 153 
outbreak. 154 
 155 
Our data also showed that a vaccinated healthcare professional who received inactivated vaccine 156 
was infected with COVID-19 while working in the isolation ward of a designated COVID-19 157 
hospital, and the coronavirus strain was determined to be the imported COVID-19 variant strain 158 
B.1.1.78, suggesting that there exists the domestic COVID-19 vaccine breakthrough infection in 159 
China, and this phenomenon deserves our serious attention. Vaccination is well-known to be key to 160 
stopping the virus from circulating and more variants from popping up11-13. The vaccine 161 
breakthrough infection case was defined as an individual with positive SARS-CoV-2 nucleic acid 162 
amplification tested after receiving at least one dose of a SARS-CoV-2 vaccine14-16. Jacobson et al17 163 
addressed post-vaccination SARS-CoV-2 infections and the incidence of the B.1.427/B.1.429 164 
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variant among healthcare personnel at a northern California academic medical center. Hacisuleyman 165 
et al18 reported two women with vaccine breakthrough infection in a cohort of 417 persons who had 166 
received the second dose of BNT162b2 (Pfizer–BioNTech) or mRNA-1273 (Moderna) vaccine at 167 
least two weeks previously, and the viral sequencing showed that they were infected with the new 168 
variant virus including E484K in 1 woman and three mutations (T95I, del142–144, and D614G) in 169 
both. These observations revealed a potential risk of COVID infection with the variant virus after 170 
successful vaccination. 171 
Vaccine breakthrough cases with SARS-CoV-2 were reported in many countries19-21. An analysis 172 
from Israel's vaccination campaign showed that COVID-19-related hospitalizations, severe disease, 173 
and death were reduced in infected cases with SARS-CoV-2 after vaccination, including 174 
symptomatic and asymptomatic infections21. Antonelli et al22 identified risk factors for post-175 
vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness, and 176 
found that Almost all symptoms were reported less frequently in infected vaccinated individuals 177 
than in infected unvaccinated individuals, and vaccinated participants were more likely to be 178 
completely asymptomatic, especially if they were 60 years or older. Our vaccine breakthrough case 179 
from Xi’an supported vaccine effectiveness and cautioned around relaxing physical distancing and 180 
other personal protective measures in the post-vaccination era. 181 
 182 
SARS-CoV-2 virus delta variants have drawn worldwide attention. The WHO proposed three labels 183 
for global SARS-CoV-2 variants, including variant of concern (VOC), variant of interest (VOI), and 184 
variant under monitoring, to be used alongside the scientific nomenclature in communications about 185 
variants to the public23. The B.1.617 variant of the COVID-19 virus has been called a triple mutant 186 
variant since it splits into three lineages including the B.1.617.1 (Kappa) variant, the B.1.617.2 187 
(Delta) variant, and the B.1.617.3 variant24. The delta COVID-19 variant, which was first detected 188 
in India in October 2020, had been reported in more than 80 countries on June 20, 202125. The WHO 189 
declared the delta variant a "variant of concern" on May 10, 2021. In Mid-June 2021, the US Centers 190 
for Disease Control and Prevention upgraded its classification of the delta from a "variant of 191 
interest" to a "variant of concern."26 Our results showed that two medical staff (1 laboratorian and 192 
1 emergency doctor), infected with COVID-19 in the designated hospital, occurred due to workplace 193 
accidental exposure to COVID-19, and the coronavirus strain was determined to be the imported 194 
B.1.617.2 (Delta) variant. 195 
 196 
To conclude, our findings add to the accumulating evidence regarding the importance of regular 197 
screening for all staff in healthcare settings. Furthermore, our study highlights the need for an update 198 
of the current hospital disinfection procedures in designated hospitals to prevent the nosocomial 199 
spread of SARS-CoV-2 infection. Finally, the epidemiological exposure of vaccinated medical staff 200 
should draw concern in order to minimize the impact of a new outbreak induced by virus mutants. 201 
 202 
Table 1: Epidemiological characteristics of sporadic nosocomial COVID-19 infections 203 
Date City Number of 
hospital/ cases 
Hospital type Profession Classification of 
infection 
Route of infection Database 
19 Jun. 
2020 
























































































































































Designated hospital: a hospital designated for treatment of imported COVID-19 cases 204 
 205 
Link 1: https://finance.sina.com.cn/china/gncj/2020-06-19/doc-iircuyvi9385332.shtml?r=9&tj=none&tr=9 206 
Link 2: https://www.zhihu.com/question/425220159 207 
Link 3: https://new.qq.com/omn/20201030/20201030A05GXU00.html 208 
Link 4: http://www.xinhuanet.com/politics/2021-01/06/c_1126953634.htm 209 
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Link 5: https://new.qq.com/omn/20201229/20201229A0259M00.html 210 
Link 6: https://new.qq.com/omn/20210111/20210111A0DFD500.html 211 
Link 7: https://news.sina.com.cn/c/2021-01-20/doc-ikftpnnx9631142.shtml 212 
Link 8: https://new.qq.com/omn/20210131/20210131A0071200.html 213 
Link 9: https://news.sina.com.cn/c/2021-03-18/doc-ikkntiam4831560.shtml 214 
Link 10: https://news.sina.com.cn/c/2021-06-14/doc-ikqcfnca0979774.shtml 215 
Link 11: http://med.china.com.cn/content/pid/281087/tid/1026 216 
Link 12: http://news.hexun.com/2021-08-18/204179459.html 217 
 218 
 219 
Table 2: Epidemiological characteristics of sporadic nosocomial COVID-19 infections 220 
Date City Confirmed/ 
asymptomatic 
cases 
How to discover the 
source of infection 
Virus type Database 
19 Jun. 
2020 
Beijing 1/0 Nucleic acid testing for 
close contacts of people 
with infection cases 
One ancestral virus strain 




Qingdao 6/6 Regular screening for 
medical staff 





Qingdao 1/0 Regular screening for 
medical staff 





Dalian 3/0 Regular screening for 
medical staff 
European family branch 1 




Dalian 1/0 Regular screening for 
medical staff 
European family branch 1 




Shenyang 12/0 Regular screening for 
medical staff 
Imported virus strain Link 6 
14 Jan. 
2021 
Shijiazhuang 14/0 Regular screening for 
medical staff 





Shanghai 2/0 Nucleic acid testing for 
close contacts of people 
with infection cases 
Imported virus strain Link 8 
17 Mar. 
2021 
Xi’an 1/0 Regular screening for 
medical staff 





Guangzhou 2/0 Regular screening for 
medical staff 
Imported virus strain 




Nanjing 4/0 Regular screening for 
medical staff 
Imported virus strain 




Yangzhou 3/0 Regular screening for 
medical staff 
Imported virus strain 
B1.617.2 (Delta) Lineage 
Link 12 
Delta Lineage: the highly contagious Covid-19 variant first identified in India 221 
 222 
Link 1: http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2020.246 223 
Link 2: http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2020.224 224 
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Link 3: https://new.qq.com/omn/20201030/20201030A05GXU00.html 225 
Link 4: http://www.xinhuanet.com/politics/2021-01/06/c_1126953634.htm 226 
Link 5: https://new.qq.com/omn/20201229/20201229A0259M00.html 227 
Link 6: https://new.qq.com/omn/20210111/20210111A0DFD500.html 228 
Link 7: http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2021.006 229 
Link 8: https://new.qq.com/omn/20210131/20210131A0071200.html 230 
Link 9: http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2021.094 231 
Link 10: https://news.sina.com.cn/c/2021-06-14/doc-ikqcfnca0979774.shtml 232 
Link 11: http://med.china.com.cn/content/pid/281087/tid/1026 233 
Link 12: http://news.hexun.com/2021-08-18/204179459.html 234 
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Figure 1: Geographical distribution of sporadic nosocomial COVID-19 infections from June 367 
2020 to June 2021 in China. Seven cities (Dalian, Beijing, Qingdao, Shijiazhuang, Xi’an, 368 
Guangzhou, and Shanghai) reported the nosocomial COVID-19 infections. Medical staff, patients 369 
and accompanying staff (12) in Shenyang (Jan 3, 2021), patients (3) in Dalian (Dec 18, 2020), 370 
patients and accompanying staff (6) in Qingdao (Oct 11, 2020), laboratory personnel (1) in Xi’an 371 
(Mar 17, 2021), medical staff, patients and accompanying staff (14) in Shijiazhuang (Jan 14, 2021), 372 
and Medical staff (2) in Guangzhou (Jun 14, 2021) were diagnosed as infected cases. 373 
 374 
 375 
Figure 2: The graph’s left-right axis is used as a timeline of the key events and dynamic profile 376 
of sporadic nosocomial COVID-19 infections from June 2020 to June 2021 in China.  377 
From June 2020 to June 2021, five cities in China had reported 10 series cases with nosocomial 378 
COVID-19 infections, including 39 confirmed cases and 6 asymptomatic cases.  379 
The delta COVID-19 variant was first detected in India in October 2020. The World Health 380 
Organization designated Delta as a variant of interest in April and a variant of concern on 11 May 381 
2021. In Mid-June 2021, the US Centers for Disease Control and Prevention upgraded its 382 
classification of delta from a "variant of interest" to a "variant of concern."  383 
 384 
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